联合镇静药物对ICU不适经历的影响分析

目的对两组联合使用镇静镇痛剂的患者进行ICU不适经历的调查。方法选取入住本院ICU的气管插管患者200例分为2组予以镇静镇痛治疗，A组：用咪达唑仑联合舒芬太尼；B组：用右美托咪定联合舒芬太尼，转出ICU3～5d后进行问卷调查。结果气管插管不适经历中，不能讲话A组低于B组；睡眠干扰B组低于A组，ICU相关不适经历中，管路或线带的约束，ICU的操作，想念家属或亲友等三项A组低于B组；噪音，见不到工作人员紧张等两项B组低于A组。结论掌握ICU住院患者不适经历，合理高效使用镇静镇痛药物，在抢救生命、治疗疾病的过程中，必须同时注意尽可能减轻患者的痛苦与恐惧感。

Objective The ICU discomfortable experience was investigated in two groups of patients with combined use of sedatives and analgesics. Methods Selected our hospital ICU patients with tracheal intubation, 200 eases were divided into two groups to calm analgesic treatment： group A with midazolam combined sufentanil while group B with midazolam combined sufentanil, the questionnaire survey was conducted after out of ICU. Results Endotracheal intubation discomfort, unable to speak in group A were lower than that in group B. Sleep disturbance in group B was lower than that in group A. In the ICU uncomfortable experience, line or line with constraints, the operation of the ICU and miss family members or friends in group A were lower than those in group B. Noise and staff tension in group B were lower than that in group A. Conclusion To master the uncomfortable experience of ICU inpatients, to use the sedative and analgesic drugs reasonably and efficiently, and to pay attention to alleviate the pain and fear of patients as much as possible in the process of saving lives and treating diseases.